Log in to search using one of your social media accounts:

This page shows you the latest items in this publication.

Patient care: More tools mean more mobility
Acceptance and integration of assistive devices in the workplace is growing, said Dr. Paul Hart, medical director at Western New York Occupational Medicine. “We work with a great group of rehab specialists, physical and occupational therapists and orthopedic specialists,” he said. “The whole thing is to get people treated as quickly as possible so they can return to full function as quickly as possible. In the past, I think the approach was very limited mobility. Now it’s “Let’s enhance… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 24, 2017 Category: Pharmaceuticals Authors: Jane Schmitt Source Type: news

Carlos Rivera
was admittedly a “happy-go-lucky” enlisted man in the U.S. Navy in the mid-1970s. He hadn’t given much consideration to his future until a colleague politely urged him to give it some thought. “He said, ‘Hey, what’s your plan?’” says Rivera, president and CEO of Vysnova Partners. “I told him I had no idea. At that point, I was in college for a couple of years and I said I guess I would finish my degree and become an officer. ‘And then what?’ he said. And he kept… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 24, 2017 Category: Pharmaceuticals Authors: Joseph Coombs Source Type: news

Ascension CEO shares plans for prime Milwaukee-area hospitals
The east side Milwaukee campus of Columbia St. Mary ’s will become an Ascension Wisconsin “center of excellence” for heart surgery and other specialty care, while Ascension’s safety-net hospital St. Joseph will discontinue some services and seek tenants to fill “repurposed” space, Ascension Wisconsin’s top executive says. Bernie Sherry , who has led Ascension Wisconsin since April 2016, shed some light on St. Louis-based Ascension’s plans for integrating locations of Columbia St. Mary’s… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 24, 2017 Category: Pharmaceuticals Authors: Rich Kirchen Source Type: news

The focus for FDA approval: Former Quintiles exec moves to Novan
Former Quintiles executive Paula Brown Stafford has joined Novan (Nasdaq: NOVN) as the company ’s chief development officer. Stafford called Quintiles home since its beginnings in the 1980s, and most recently served as its president of clinical development before departing the multibillion-dollar contract research organization in 2015. Quintiles merged with Danbury, Connecticut-based IMS H ealth to form QuintilesIMS last year. “We’re extremely excited to have Paula Brown Stafford on board,”… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 23, 2017 Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news

CVS, Pitt launch new initiative to fight youth drug abuse
The University of Pittsburgh School of Pharmacy, Pittsburgh Public Schools and CVS Health on Thursday launched an initiative to bring a drug prevention program to the school system. Pharmacists Teach is a two-year program that CVS (NYSE: CVS) launched with the Partnership for Drug-Free Kids to alert children to the dangers of prescription drug abuse. Students from Pitt's pharmacy school will be involved in the teaching. "CVS Health is committed to addressing and preventing p rescription drug abuse… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 23, 2017 Category: Pharmaceuticals Authors: Paul J. Gough Source Type: news

AtlasMD building reputation for lowering costs
Mick Lowderman couldn ’t afford to offer health insurance for his employees at Go Green Pest Control Services Inc. But he knew something had to give when a person who had been with the company for three years left the organization for a lesser-paying job at another business that offered health insurance benefits. So Lowderman looked for options and discovered Dr. Josh Umbehr’s AtlasMD, a membership-based health care business that allows patients to bypass the insurance requirements often associated… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 23, 2017 Category: Pharmaceuticals Authors: Josh Heck Source Type: news

Mercy buys property for $2.4 million, plans new facility
Mercy has purchased the site of a former golf driving range in north St. Louis County near Florissant for $2.4 million. The health system bought the property at 3555 N. Highway 67, which previously was the North County Golf& Sports Center, from Ronald and Ann Brand. The 17-acre property, which is now vacant, had an appraised value of $1.01 million, according to St. Louis County real estate records. The St. Louis County Council approved a request from Mercy to rezone the property as a planned commercial… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 23, 2017 Category: Pharmaceuticals Authors: Angela Mueller Source Type: news

Ed Goldman: Sutter ’s CEO says Health Care Act issues change “hourly”
Dave Cheney, the still-new CEO of Sutter Medical Center, told attendees at a private luncheon yesterday that it does “absolutely no good to predict what’s going to happen” with the American Health Care Act, a topic on everyone’s mind today as Congress begins to grapple with its passage. “In previous administrations, you had a pretty good idea of how things were going to go by the time of the inauguratio n,” he tells members of the Sutter Medical Foundation, “or at least a few months… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 23, 2017 Category: Pharmaceuticals Authors: Ed Goldman Source Type: news

Flexion tops $800M in market cap on Sanofi buyout rumor
Shares of Burlington biotech Flexion Therapeutics soared to their highest point in more than a year and a half on Thursday following an unconfirmed report that French drug giant Sanofi is in talks to acquire the company for more than $1 billion. FiercePharma, citing an unnamed source, reported Thursday morning that the board of Flexion (Nasdaq: FLXN) has voted to accept a non-binding offer from Sanofi (NYSE: SNY), the parent company of Cambridge-based Sanofi-Genzyme. The offer values Flexion at… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 23, 2017 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news

Q & A: Froedtert cancer-center innovator Derus retires
Sue Derus says she doesn ’t like to “toot my own horn” but she’s credited with driving tremendous innovation and change in Froedtert Health’s cancer services the past 11 years as executive director. Derus, 65, recently retired from Froedtert& the Medical College of Wisconsin Clinical Cancer Center in Wauwatosa after 40-plus years in the field that started with clinical work as a radiation therapist. Froedtert promoted from within for Derus ’ replacement, naming Tina Curtis, who formerly… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 23, 2017 Category: Pharmaceuticals Authors: Rich Kirchen Source Type: news

$10M Housing expansion proposed at VA campus
Developers are proposing doubling the size of a housing development on the campus of the Dayton VA Medical Center. Dayton-based St. Mary Development Corp. is looking at the $10 million, 55-unit McBride Place project as an expansion of the standing Lyons Place II development, an independent living facility for low-income seniors and with preferential placement for veterans 62 and older. That facility has been f illed, said Wes Young, v ice president and chief real estate officer of St. Mary Development… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 23, 2017 Category: Pharmaceuticals Authors: Tristan Navera Source Type: news

Stocks, Dow, investors brace for Trump ’s big Obamacare vote
The Dow Jones Industrial Average, Nasdaq and S&P 500 started out flat but moved up Thursday morning as markets and investors look for clues and wait for the big Obamacare repeal vote in the U.S. House of Representatives later today. The Nasdaq was down about 11 points early on but was later up about 16 points. The Dow started up and down and was up just under 5 points at a little over 45 minutes into trading before moving down 7 points. The Dow later moved up more than 40 and then 78 points in… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 23, 2017 Category: Pharmaceuticals Authors: Mike Sunnucks Source Type: news

UH cancer center, medical school getting energy storage pilot projects
Hawaiian Electric Co. (NYSE: HE) and the University of Hawaii are working on a couple of battery energy storage pilot projects at the university ’s cancer center and medical school in the Honolulu neighborhood of Kakaako to see if these projects can deliver energy services to support the grid for the benefit of all customers, the two entities confirmed to Pacific Business News this week. Peter Rosegg, spokesman for Hawaiian Electric, told PBN that the goal of this “Demand Response” demonstration… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 22, 2017 Category: Pharmaceuticals Authors: Duane Shimogawa Source Type: news

Health care facility design and construction
As the Puget Sound region continues to grow and evolve, more health care facilities will be necessary to meet growing demand. The Puget Sound Business Journal recently held a Thought Leader Forum with industry leaders about important issues to consider when making decisions regarding health care facility design and construction. The Puget Sound Business Journal Thought Leader Forum participants were Keith Honsberger, Senior Vice President, Kidder Mathews; Mark Howell, Senior Vice President, Skanska;… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2017 Category: Pharmaceuticals Source Type: news

N. Va. hospital seeks to grow by another 100 beds
Virginia Hospital Center wants to add 100 more inpatient beds to its Arlington hospital campus as part of its planned expansion onto an adjacent piece of land vacated by the county. The 357-bed hospital requested approval from Virginia regulators to add the beds in conjunction with an expansion and relocation of its outpatient services to a 5-acre parcel on Edison Street next to the hospital. That plan calls for a 140,000-square-foot outpatient building to be built atop and adjacent to a new parking… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2017 Category: Pharmaceuticals Authors: Tina Reed Source Type: news

Biogen prevails in dispute over key Tecfidera patent
A panel of judges has upheld a key patent on Biogen ’s blockbuster multiple sclerosis treatment Tecfidera, rejecting a challenge filed by hedge fund manager Kyle Bass last year. The Patent Trial and Appeal Board on Tuesday upheld the validity of the patent, which relates to the dosage of Tecfidera’s key ingredient. Since coming onto the market i n 2013, the drug has emerged as Biogen’s biggest moneymaker, accounting for nearly $4 billion of the company’s $11.4 billion in total revenues in… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2017 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news

FDA approves Center City firm's device to simplify tube feeding
The Food and Drug Administration has granted marketing authorization to a device developed by a Philadelphia company to improve the administration of tube feeding. Trovita Health Science's device, called Safe-T Feed, simplifies the tube-feeding process from more than 60 steps to just seven, and eliminates pouring nutritional formulas into an open syringe or gravity bag for feedings. Will Brown, the company’s CEO, said Trovita’s delivery system features ready-to-feed pouch’s with a capless,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2017 Category: Pharmaceuticals Authors: John George Source Type: news

Exclusive: Why a former Portland health titan is leaving the Pacific NW for a startup
Leaving the corporate insurance world after a quarter century to become a startup's fourth employee may sound like a huge risk, but Don Antonucci says it's the perfect time and opportunity. "I knew that this was sort of one of those deciding points in a career," Antonucci said in an interview. "If I didn’t take the opportunity, I would regret it." Antonucci has served as Regence BlueShield of Washington president since 2013, but has held many roles in different Blue Shield and oth er insurance… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2017 Category: Pharmaceuticals Authors: Coral Garnick Source Type: news

Healthcare: Trump lobbying; genetic tests jeopardized
Lobbying. President Donald Trump is on Capitol Hill pushing for House Republicans to pass the new healthcare bill. Small changes were made to appeal to conservatives, The Hill reports. They include allowing states to require that Medicaid recipients work and building more flexibility into the proposed block grant program. Tax credits for older Americans buying individual insurance also would be increased. Meanwhile, the American Hospital Association, AARP and the American Medical Association are… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2017 Category: Pharmaceuticals Source Type: news

MD Interconnect CMO on growth beyond Triangle
Raleigh-based health care technology company MD Interconnect is in the process of expanding its reach beyond the Triangle, according to co-founder and Chief Medical Officer Dr. David Hoover. As part of that process, MD Interconnect has inked a new partnership with Boston-based MedAptus that will combine MD Interconnect’s RapidConnect messaging solution for health care professionals with MedAptus’ Assign patient assignment technology, according to the companies. “There are other secure communications… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2017 Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news

Exclusive: Sunnyvale healthcare analytics startup hires Mayo Clinic veteran as CEO
Viewics, a Sunnyvale startup whose platform is used to apply data analytics to improve healthcare management, has hired longtime Mayo Clinic executive Keith Laughman as its new CEO. Co-founder Dhiren Bhatia is shifting from being CEO to a new role as chief strategy officer to focus on strategic direction, product and business development, and partnerships. Click here to get the free daily TechFlash Silicon Valley newsletter. Laughman was with Mayo for 29 years, helping deve lop and execute strategy… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2017 Category: Pharmaceuticals Authors: Cromwell Schubarth Source Type: news

Prime Healthcare names overall leader for its area hospitals
Prime Healthcare Services Inc., which owns four area hospitals, has selected Randy Nyp to oversee the California-based for-profit hospital operator's Kansas City market, The Kansas City Star reports. As CEO of Prime Healthcare's local market, Nyp now oversees the leaders at Providence Medical Center in Kansas City, Kan., St. Joseph Medical Center in Kansas City, St. Mary's Medical Center in Blue Springs, and Saint John Hospital in Leavenworth, as well as 31 physician practices and clinics. Be fore… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2017 Category: Pharmaceuticals Authors: Andrew Vaupel Source Type: news

What Trump's budget proposal could mean for UAB
The budget proposal unveiled by President Donald Trump last week calls for significant funding cuts for a number of agencies and government entities that would affect Birmingham. But one of the most significant impacts to the Magic City's business world could be the nearly 20 percent budget cut proposed for the National Institutes of Health, which funds hundreds of millions of dollars per year in research at the University of Alabama at Birmingham. Chris Brown, vice presi dent of research at UAB,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 20, 2017 Category: Pharmaceuticals Authors: Ty West Source Type: news

Mayo CEO says he regrets his comments on Medicare, Medicaid 'caused concerns'
Mayo Clinic CEO Dr. John Noseworthy regrets that his use of the word "prioritized" in a speech raised concerns that Mayo wouldn't care for patients covered by Medicaid and Medicare, according a written statement released Friday. The statement came in response to media coverage of a speech Noseworthy made to Mayo staff last year. In that talk, Noseworthy said that all other things being equal, the clinic would prioritize patients with private insurance over those covered by public programs. The Star… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 20, 2017 Category: Pharmaceuticals Authors: Katharine Grayson Source Type: news

CEO of SCL Health hospital system is departing
Mike Slubowski, the CEO who oversaw SCL Health ’s relocation to Denver and the expansion of the health system’s services, is leaving Colorado to lead one of the nation’s largest faith-based health systems. Slubowski will become president and COO of Trinity Health in Novi, Michigan — they system where he worked for 14 years, most recentl y as president of health networks, before heading up SCL Health. Broomfield-based SCL, whose headquarters Slubowski moved from Kansas, operates Saint Joseph… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 20, 2017 Category: Pharmaceuticals Authors: Ed Sealover Source Type: news

UNC Health: 1,300 patients could be impacted by 'possible information breach'
UNC Health Care said Monday that it is in the process of notifying 1,300 prenatal patients who could be impacted by a “possible information breach.” These patients had appointments between April 2014 and last month at either the Women’s Clinic at N.C. Women’s Hospital or UNC Maternal-Fetal Medicine at Rex, according to UNC Health Care. The possible breach involves pregnancy home-risk screening forms, UNC Health Care stated. While these forms “were used to collect personal information… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 20, 2017 Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news

​Greater Cincinnati health district closer to building $5M HQ
Construction is to begin in May on a multimillion-dollar million headquarters for the Northern Kentucky Health Department, which plans to consolidate four offices into a new building in Florence. Work on the two-story building, which will encompass up to 40,000 square feet, is to be completed by January 2018. I reported last year on plans to build the new headquarters. Members of the District Board of Health recently voted to enter into a contract with Hemmer Construction of Covington for a design/build… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 20, 2017 Category: Pharmaceuticals Authors: Barrett J. Brunsman Source Type: news

Judge sides with HCA over Jackson in battle for new hospital
Jackson Health System ’s plan to build a hospital in Doral received a serious blow, while HCA Corp.’s hospital proposal was bolstered, after a ruling by a state judge. The public health system for Miami-Dade County is competing with HCA (NYSE: HCA) in the state’s certificate of need (CON) process to build a hospit al in fast-growing Doral. In 2015, the Florida Agency for Health Care Administration granted preliminary approval to JHS’ plan for the 100-bed Jackson West and preliminary denial… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 20, 2017 Category: Pharmaceuticals Authors: Brian Bandell Source Type: news

Site plans approved for West County replacement hospital
The city of Creve Coeur has approved BJC HealthCare ’s site development plan for the new Barnes-Jewish West County Hospital. BJC plans to build a 260,000-square-foot hospital to replace the existing 77-bed Barnes-Jewish West County facility. An adjoining four-story medical office building also is included in the site plan, which was approved by th e Creve Coeur City Council at its meeting last week. BJC plans to break ground on the project soon, with the new hospital slated to open in 2019. BJC’s… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 20, 2017 Category: Pharmaceuticals Authors: Angela Mueller Source Type: news

Rand Paul calls for greater competition to drive down health care prices
U.S. Sen. Rand Paul said he hopes the current Republican health care reform bill fails its vote in the U.S. House of Representatives on Thursday. Paul, R-Ky. made the remarks this morning during a gathering of about 100 people at an event hosted by the St. Matthews Chamber of Commerce at the St. Matthews Community Center. Paul said the current Republican health care reform plan — which he called “Obamacare Lite” — would result in h ealth insurance companies “socializing the losses and… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 20, 2017 Category: Pharmaceuticals Authors: Chris Larson Source Type: news

Providence CEO takes out full-page ad in The Seattle Times to apologize
Providence St. Joseph Health CEO Dr. Rod Hochman is taking responsibility and apologizing to the caregivers, physicians, patients and community members for the "pain the current situation" at Swedish Health Services' neurosurgery unity has caused. "I am ultimately accountable for the successes and mistakes of the hospitals in our system," Hochman wrote in a full-page community message advertisement in the Sunday print edition of The Seattle Times. "I hope we can learn from this and move forward… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 20, 2017 Category: Pharmaceuticals Authors: Coral Garnick Source Type: news

Novan ’s loss grew in 2016, but optimistic on development
Novan ’s (Nasdaq: NOVN) net loss grew in 2016, but it remains optimistic on development. The company – which is developing a treatment for acne without the use of antibiotics – reported a net loss of $59.7 million in 2016, up from a net loss of $28.1 million the year prior. Novan said in an announ cement of its fourth quarter and full-year results Monday that its research and development expenses increased from $16.6 million in 2015 to $46.5 million in 2016 “due primarily to increased development… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 20, 2017 Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news

Emergent BioSolutions gets $100 million anthrax contract from feds
Gaithersburg-based Emergent BioSolutions Inc. won another lucrative anthrax contract from the feds, this time totaling $100 million over two years. Emergent (NYSE: EBS) received the contract through the Biomedical Advanced Research and Development Authority to add more of its anthrax vaccine, BioThrax, to the country's national stockpile. The company first announced the planned purchase in December, along with another Centers for Disease Cont rol and Prevention contract worth up to $911 million for… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 20, 2017 Category: Pharmaceuticals Authors: Tina Reed Source Type: news

An anonymous blogger angers biotech investors. But are his posts illegal?
For the past year and a half, an anonymous investor by the name of Mako Research has angered investors and executives alike with a series of blog posts accusing small companies — mostly tech and biotech firms — of financial fraud, “Ponzi schemes,” pending collapse and worse. Some of the claims in the 14 articles posted since August 2015 on a popular investor website are false, or at best, misleading. Many are couched as opinion, citing unnamed experts that appear to give the blogs authority.… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 20, 2017 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news

Manoa Botanicals CEO says cash-based medical marijuana business will be safe
Security and cash were some of the topics discussed at the Hawaii Society of Business Professional ’s luncheon on Thursday, which featured a panel on the state’s medical marijuana program, with Manoa Botanicals CEO Brian Goldstein assuring the audience that his cash-based operation will be safe. “You can feel very comfortable that our facility is going to be the safest place on the block,” said Goldstein, who has yet to publicly disclose the location of his cultivation facility and dispensaries. “The… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 18, 2017 Category: Pharmaceuticals Authors: Anna Hrushka Source Type: news

FIRST LOOK: Children ’s Hospital reveals cost, appearance of biggest project ever
Cincinnati Children ’s Hospital Medical Center expects construction of a massive patient tower and related infrastructure on the Avondale campus to cost up to $650 million, making it the most expensive project ever undertaken by the nonprofit. “In current dollars, this will be the largest single investment that ou r institution has ever made,” said Michael Fisher, CEO of the hospital. “When I say single investment, you’ve got to understand this includes the clinical space (in the 650,000-square-foot… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 17, 2017 Category: Pharmaceuticals Authors: Barrett J. Brunsman Source Type: news

Analyst: Trump budget's FDA fee hikes would hurt smaller Seattle biotech companies
President Donald Trump ’s proposed 2018 budget doesn’t spare Seattle-area biotechnology companies, which have remained cautiously optimistic that the new administration would go easy on the industry after a rollercoaster election season that sent stock prices tumbling. The budget “blueprint” would sharply increas e user fees that the Food and Drug Administration charges drug companies and medical-device makers to review their products, more than doubling current user fees to $2 billion a year. FDA… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 17, 2017 Category: Pharmaceuticals Authors: Casey Coombs Source Type: news

Proteon CEO: New trial could be a path to market
After Proteon Therapeutics Inc.'s chronic kidney disease treatment failed a late clinical trial, the company is forging forward with a new plan that could take the drug to market. The Waltham, Mass.-based company's treatment, vonapanitase, was originally developed by Kansas City entrepreneur Nick Franano. It's intended to help maintain blood flow through an arteriovenous fistula (AVF), a connection between an artery and a vein, used for patients on dialysis. "What we're tr ying to do is not just… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 17, 2017 Category: Pharmaceuticals Authors: Elise Reuter Source Type: news

Baylor Scott & White CEO weighs in on what ’s wrong with U.S. health care
As the Republican health care bill debate rages in Washington D.C., the new CEO of Dallas-based Baylor Scott& White Health called for common ground, patience and perspective. Jim Hinton took the helm in January at Baylor Scott& White, the largest not-for-profit health care system in Texas and one of the largest in the country, including a growing presence in the Austin area. He previously was chief executive of Presbyterian Healthcare Services in Albuquerque. The House Budget Committee voted… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 17, 2017 Category: Pharmaceuticals Authors: Bill Hethcock Source Type: news

How N.C.'s proposed 'pollinator protection' bill could impact Bayer, Syngenta
Big Ag companies in Research Triangle Park are speaking out against a just-filed bill in the North Carolina General Assembly intended to protect honey bee colonies. Called the Pollinator Protection Act, the bill would limit the use of a common family of pest control chemicals: neonicotinoid pesticides. In the bill text, lawmakers link "excessive honey bee mortality" with their use, but manufacturers of the chemical say that's just not true. Becky Langer, hea d of Bayer’s RTP-based North American… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 17, 2017 Category: Pharmaceuticals Authors: Lauren K. Ohnesorge Source Type: news

Area hospitals prepare for physician shortage
With updated data projecting a potential physician shortage of more than 100,000 nationwide by 2030, Pittsburgh's smaller regional hospitals have already begun planning for the future. According to a report released this week by the Association of American Medical Colleges, the U.S. is projected to experience a dearth of between 7,300 and 43,100 primary care physicians, and between 33,500 and 61,800 nonprimary specialists by 2030. Dr. Alan Yeasted, chief medical officer at St. Clair Hospital, said… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 17, 2017 Category: Pharmaceuticals Authors: Lydia Nuzum Source Type: news

Durham's Argos Therapeutics may file for bankruptcy
Amid a workforce reduction stemming from a recommendation to discontinue a Phase 3 trial known as ADAPT of its lead oncology product candidate and uncertainties about its previously planned expansion and incentives in Durham, Argos Therapeutics (Nasdaq: ARGS) says it needs to raise capital to continue operations. The company disclosed in its annual report filed with the SEC Thursday that it does "not have sufficient cash resources to pay all of our accrued obligations in full or to continue our… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 17, 2017 Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news

TGen study of ASU football team produces largest known dataset for concussion diagnostics
Researchers at the Translational Genomics Research Consortium have finished a 3-year study of the Arizona State University football program, and now their results are being published in Scientific Reports, an online open-access journal of the Nature Publishing Group. With this study, TGen researchers have collected the largest dataset of extracellular small RNAs, which are potential biomarkers for diagnosing medical conditions, including concussions. A portion of the information collected from… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 17, 2017 Category: Pharmaceuticals Authors: Angela Gonzales Source Type: news

Thanks to Jennifer Lawrence, children's hospital to get $78M makeover
Thanks to award-winning actress Jennifer Lawrence, a Louisville children's hospital will have state-of-the-art care for its young heart patients. Norton Healthcare Inc. is investing $78.3 million in Norton Children's Hospital in Louisville after receiving a $2 million donation from the Jennifer Lawrence Foundation. Lawrence, a native of Louisville, pledged the money in February, and challenged others to give. Since then, the Children’s H ospital Foundation has raised $10 million of a $20 million… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 17, 2017 Category: Pharmaceuticals Authors: Chris Larson Source Type: news

Proteon CEO: New trial could be a path to market
After Proteon Therapeutics Inc.'s chronic kidney disease treatment failed a late clinical trial, the company is forging forward with a new plan that could take the drug to market. The Waltham, Mass.-based company's treatment, vonapanitase, was originally developed by Kansas City entrepreneur Nick Franano. It's intended to help maintain blood flow through an arteriovenous fistula (AVF), a connection between an artery and a vein, used for patients on dialysis. "What we're tr ying to do is not just… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 17, 2017 Category: Pharmaceuticals Authors: Elise Reuter Source Type: news

Now this: Activist investor appears ready to take on CHS
Community Health Systems, the struggling Franklin-based hospital company, could soon have extra encouragement to get its financial house in order — from an activist investor. The company’s (NYSE: CYH) largest shareholder filed paperwork this week that indicates he could shift from being a passive to an activist investor, according to Modern Healthcare. In a regulatory filing this week, Chinese billionaire Tianqiao Chen noted that his 15 .6 million shares of CHS, representing a 13.7 percent stake,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 17, 2017 Category: Pharmaceuticals Authors: Eric Snyder Source Type: news

Barnes-Jewish adds board members
Barnes-Jewish Hospital, the region's largest hospital, has added Susan Goldberg and Tom Hillman to its board. Hillman is general partner of Lewis& Clark Ventures and managing principal of FTL Capital. He is executive chairman of Pulse Therapeutics and is on the advisory board of Automation Service. Goldberg, a former first-grade teacher and marketing professional, is a community volunteer who has served on a variety of local boards such as the Foundation for Barnes-Jewish Hospital, Jewish Federation… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 17, 2017 Category: Pharmaceuticals Authors: Angela Mueller Source Type: news

Replacing ACA would hike GA Medicaid costs
Republican Gov. Nathan Deal and GOP leaders in the General Assembly argued they were being fiscally prudent when they declined to expand Georgia ’s Medicaid program under the Affordable Care Act. But that decision could come back to haunt the Peach State if the Republican Congress passes the American Health Care Act, the replacement for Obamacare introduced into the U.S. House of Representatives this month. Georgia and 18 other states th at chose not to extend Medicaid coverage to individuals with… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 17, 2017 Category: Pharmaceuticals Authors: Dave Williams Source Type: news

Searching for a sign: Navigating the Buffalo Niagara Medical Campus
For nine years, Kerri Lucas has made the trip downtown from her Town of Tonawanda home to bring her son William for treatment at Women& Children ’s Hospital of Buffalo. Born prematurely at 24 weeks with hydrocephalus, William has had 16 brain surgeries. His appointments range from the neurology department for a seizure disorder and audiology for a hearing impairment and urology for malfunctioning kidneys and endocrinology for hormonal gro wth issues. With the hospital set to move to the Buffalo… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 17, 2017 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

Hospital and Med School construction add challenges to reaching destination
Walking across the medical campus can be a bit more confusing than it once was. That ’s what I found recently when I walked out a side door of Buffalo General Medical Center and got turned around. Though I’d been to the campus dozens of times, I couldn’t tell if the building in front of me was the new John R. Oishei Children’s Hospital or the Conventus medical office buildin g. If I could get confused so easily, I could only imagine how a first-timer to the campus might feel or someone who… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 17, 2017 Category: Pharmaceuticals Authors: Staff Report Source Type: news